What does the current evidence tell us about the cardiovascular impact of novel tobacco and nicotine products?

In this presentation from Global Forum on Nicotine 2026, Dr. Thomas Nahde discusses a narrative review examining cardiovascular health and the potential impact of switching from combustible cigarettes to non-combustible nicotine products.

The review brings together 221 publications, covering experimental research, clinical studies and population-level evidence. It examines cardiovascular toxicant exposure, biomarkers of potential harm, atherosclerosis-related mechanisms, and evidence surrounding e-cigarettes, heated tobacco products and nicotine pouches.

The Global Forum on Nicotine (GFN) has taken place every year since 2014 and is the only international conference to focus on how vapes, nicotine pouches, Swedish snus and heated tobacco can help people switch away from smoking. Building on the success of an event that attracts hundreds of in-person participants and thousands of online delegates, this is the homepage of GFN•TV, the broadcast arm of the GFN stable.

GFN•TV regularly broadcasts GFN•TV news and interviews, given by Brent Stafford. We also livestream the annual GFN conference, live from Warsaw and release all the session videos and GFN•TV Commentary Team discussions post event.

Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments.

From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.